BCDA Stock Summary and Trading Ideas (Biocardia | NASDAQ:BCDA)

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

What symbol and exchange does Biocardia shares trade?

Biocardia trades on the NASDAQ stock market under the symbol BCDA.

What is Biocardia stock price doing today?

As of September 11, 2026, BCDA stock price declined to $1.08 with 134,499 million shares trading.

What is Biocardia's Beta?

BCDA has a beta of -0.32, meaning it tends to be less sensitive to market movements. BCDA has a correlation of 0.00 to the broad based SPY ETF.

How much is Biocardia worth?

BCDA has a market cap of $16.35 million. This is considered a Sub-Micro Cap stock.

What is the highest and lowest price Biocardia traded in the last 3 year period?

In the last 3 years, BCDA traded as high as $23.25 and as low as $.75.

What are the top ETFs holding Biocardia?

The top ETF exchange traded funds that BCDA belongs to (by Net Assets): VXF, VTI.

Is Biocardia (BCDA) a good investment?

BCDA has underperformed the market in the last year with a price return of -52.4% while the SPY ETF gained +17.4%. However, in the short term, BCDA had mixed performance relative to the market. It has outperformed in the last 3 months, returning +35.8% vs +3.9% return in SPY. But in the last 2 weeks, BCDA shares have been beat by the market, returning -6.1% compared to an SPY return of -0.7%.

What are the support and resistance levels for Biocardia (BCDA)?

BCDA support price is $1.05 and resistance is $1.15 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BCDA shares will trade within this expected range on the day.